Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
ICUI's Cash to Debt is ranked higher than
90% of the 309 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.30 vs. ICUI: No Debt )
ICUI' s 10-Year Cash to Debt Range
Min: 1.75   Max: No Debt
Current: No Debt

Equity to Asset 0.93
ICUI's Equity to Asset is ranked higher than
98% of the 303 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. ICUI: 0.93 )
ICUI' s 10-Year Equity to Asset Range
Min: 0.85   Max: 0.96
Current: 0.93

0.85
0.96
Interest Coverage No Debt
ICUI's Interest Coverage is ranked higher than
84% of the 206 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.96 vs. ICUI: No Debt )
ICUI' s 10-Year Interest Coverage Range
Min: 9999.99   Max: 9999.99
Current: No Debt

F-Score: 5
Z-Score: 19.65
M-Score: -2.97
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 15.21
ICUI's Operating margin (%) is ranked higher than
85% of the 307 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.78 vs. ICUI: 15.21 )
ICUI' s 10-Year Operating margin (%) Range
Min: 7.83   Max: 34.17
Current: 15.21

7.83
34.17
Net-margin (%) 11.80
ICUI's Net-margin (%) is ranked higher than
84% of the 307 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.12 vs. ICUI: 11.80 )
ICUI' s 10-Year Net-margin (%) Range
Min: 6.62   Max: 22.42
Current: 11.8

6.62
22.42
ROE (%) 7.60
ICUI's ROE (%) is ranked higher than
75% of the 302 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.58 vs. ICUI: 7.60 )
ICUI' s 10-Year ROE (%) Range
Min: 3.2   Max: 14.42
Current: 7.6

3.2
14.42
ROA (%) 7.10
ICUI's ROA (%) is ranked higher than
82% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.35 vs. ICUI: 7.10 )
ICUI' s 10-Year ROA (%) Range
Min: 3.03   Max: 13.57
Current: 7.1

3.03
13.57
ROC (Joel Greenblatt) (%) 29.43
ICUI's ROC (Joel Greenblatt) (%) is ranked higher than
83% of the 307 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.02 vs. ICUI: 29.43 )
ICUI' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 9.36   Max: 69.49
Current: 29.43

9.36
69.49
Revenue Growth (%) 0.20
ICUI's Revenue Growth (%) is ranked lower than
73% of the 280 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.20 vs. ICUI: 0.20 )
ICUI' s 10-Year Revenue Growth (%) Range
Min: 0.2   Max: 34.6
Current: 0.2

0.2
34.6
EBITDA Growth (%) -0.10
ICUI's EBITDA Growth (%) is ranked higher than
66% of the 235 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.70 vs. ICUI: -0.10 )
ICUI' s 10-Year EBITDA Growth (%) Range
Min: -19.8   Max: 35.1
Current: -0.1

-19.8
35.1
EPS Growth (%) 7.10
ICUI's EPS Growth (%) is ranked higher than
74% of the 236 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.10 vs. ICUI: 7.10 )
ICUI' s 10-Year EPS Growth (%) Range
Min: -32.2   Max: 66
Current: 7.1

-32.2
66
» ICUI's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

ICUI Guru Trades in Q3 2013

Steven Cohen 9,814 sh (New)
Mario Gabelli 48,033 sh (+75.73%)
Jim Simons 394,600 sh (+55.6%)
Paul Tudor Jones 9,000 sh (+52.54%)
John Hussman Sold Out
Mariko Gordon Sold Out
Chuck Royce 16,300 sh (-30.04%)
» More
Q4 2013

ICUI Guru Trades in Q4 2013

Joel Greenblatt 133,533 sh (New)
Paul Tudor Jones 15,959 sh (+77.32%)
Jim Simons 598,500 sh (+51.67%)
Mario Gabelli 69,733 sh (+45.18%)
Steven Cohen Sold Out
Chuck Royce 700 sh (-95.71%)
» More
Q1 2014

ICUI Guru Trades in Q1 2014

Steven Cohen 3,930 sh (New)
Joel Greenblatt 242,621 sh (+81.69%)
Mario Gabelli 115,000 sh (+64.91%)
Jim Simons 732,201 sh (+22.34%)
Chuck Royce 700 sh (unchged)
Paul Tudor Jones 4,115 sh (-74.22%)
» More
Q2 2014

ICUI Guru Trades in Q2 2014

Paul Tudor Jones 84,249 sh (+1947.36%)
Mario Gabelli 125,600 sh (+9.22%)
Chuck Royce 700 sh (unchged)
Joel Greenblatt 224,111 sh (-7.63%)
Jim Simons 645,500 sh (-11.84%)
» More
» Details

Insider Trades

Latest Guru Trades with ICUI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2014-03-31 Add 81.69%0.1%$56.75 - $66.2 $ 62.682%242621
Mario Gabelli 2014-03-31 Add 64.91%0.01%$56.75 - $66.2 $ 62.682%115000
Joel Greenblatt 2013-12-31 New Buy0.2%$60.86 - $68.32 $ 62.68-2%133533
Mario Gabelli 2013-12-31 Add 45.18%0.01%$60.86 - $68.32 $ 62.68-2%69733
Mariko Gordon 2013-09-30 Sold Out 1.9%$67.84 - $75.9 $ 62.68-12%0
John Hussman 2013-09-30 Sold Out 0.05%$67.84 - $75.9 $ 62.68-12%0
Mario Gabelli 2013-09-30 Add 75.73%0.01%$67.84 - $75.9 $ 62.68-12%48033
Mariko Gordon 2013-06-30 New Buy1.9%$58.34 - $75.7 $ 62.68-5%550761
Joel Greenblatt 2013-06-30 Sold Out 0.13%$58.34 - $75.7 $ 62.68-5%0
John Hussman 2013-06-30 Reduce -48.15%0.03%$58.34 - $75.7 $ 62.68-5%14000
Mario Gabelli 2013-06-30 Add 22.39%$58.34 - $75.7 $ 62.68-5%27333
John Hussman 2013-03-31 New Buy0.06%$56.07 - $63.91 $ 62.684%27000
Joel Greenblatt 2012-03-31 Add 68.36%0.08%$44.41 - $49.53 $ 62.6844%44727
Joel Greenblatt 2011-12-31 Add 74.83%0.06%$35.99 - $45.53 $ 62.6852%26566
Joel Greenblatt 2011-09-30 Add 59.36%0.03%$36.41 - $45.79 $ 62.6854%15195
Joel Greenblatt 2011-06-30 New Buy0.06%$41.23 - $45.21 $ 62.6844%9535
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about ICU Medical Inc

Weekly CEO Buys Highlight: GE, ICUI, OPK, CLMS, AHH
According to GuruFocus Insider Data, these are the largest CEO buys during the past week. The overall trend of CEOs is illustrated in the chart below: Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 26.30
ICUI's P/E(ttm) is ranked higher than
83% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 34.10 vs. ICUI: 26.30 )
ICUI' s 10-Year P/E(ttm) Range
Min: 13.77   Max: 106.63
Current: 26.3

13.77
106.63
P/B 1.97
ICUI's P/B is ranked higher than
83% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.17 vs. ICUI: 1.97 )
ICUI' s 10-Year P/B Range
Min: 1.4   Max: 3.45
Current: 1.97

1.4
3.45
P/S 3.10
ICUI's P/S is ranked higher than
72% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.03 vs. ICUI: 3.10 )
ICUI' s 10-Year P/S Range
Min: 1.73   Max: 6.58
Current: 3.1

1.73
6.58
PFCF 19.90
ICUI's PFCF is ranked higher than
92% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 127.16 vs. ICUI: 19.90 )
ICUI' s 10-Year PFCF Range
Min: 11.24   Max: 98.42
Current: 19.9

11.24
98.42
EV-to-EBIT 13.67
ICUI's EV-to-EBIT is ranked higher than
90% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 24.10 vs. ICUI: 13.67 )
ICUI' s 10-Year EV-to-EBIT Range
Min: 7   Max: 71.3
Current: 13.67

7
71.3
PEG 3.70
ICUI's PEG is ranked higher than
87% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. ICUI: 3.70 )
ICUI' s 10-Year PEG Range
Min: 0.6   Max: 158.4
Current: 3.7

0.6
158.4
Shiller P/E 24.61
ICUI's Shiller P/E is ranked higher than
91% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. ICUI: 24.61 )
ICUI' s 10-Year Shiller P/E Range
Min: 16.43   Max: 37.93
Current: 24.61

16.43
37.93
Current Ratio 15.21
ICUI's Current Ratio is ranked higher than
97% of the 238 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.92 vs. ICUI: 15.21 )
ICUI' s 10-Year Current Ratio Range
Min: 5.86   Max: 23.06
Current: 15.21

5.86
23.06
Quick Ratio 13.82
ICUI's Quick Ratio is ranked higher than
97% of the 238 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.84 vs. ICUI: 13.82 )
ICUI' s 10-Year Quick Ratio Range
Min: 4.57   Max: 22
Current: 13.82

4.57
22

Valuation & Return

vs
industry
vs
history
Price/Net Cash 3.40
ICUI's Price/Net Cash is ranked higher than
96% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. ICUI: 3.40 )
ICUI' s 10-Year Price/Net Cash Range
Min: 2.24   Max: 575
Current: 3.4

2.24
575
Price/Net Current Asset Value 2.88
ICUI's Price/Net Current Asset Value is ranked higher than
96% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. ICUI: 2.88 )
ICUI' s 10-Year Price/Net Current Asset Value Range
Min: 2.05   Max: 83.33
Current: 2.88

2.05
83.33
Price/Tangible Book 2.00
ICUI's Price/Tangible Book is ranked higher than
88% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.22 vs. ICUI: 2.00 )
ICUI' s 10-Year Price/Tangible Book Range
Min: 1.37   Max: 4.51
Current: 2

1.37
4.51
Price/DCF (Projected) 1.25
ICUI's Price/DCF (Projected) is ranked higher than
91% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.31 vs. ICUI: 1.25 )
ICUI' s 10-Year Price/DCF (Projected) Range
Min: 0.79   Max: 2.63
Current: 1.25

0.79
2.63
Price/Median PS Value 1.06
ICUI's Price/Median PS Value is ranked higher than
79% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.15 vs. ICUI: 1.06 )
ICUI' s 10-Year Price/Median PS Value Range
Min: 0.59   Max: 2.45
Current: 1.06

0.59
2.45
Price/Peter Lynch Fair Value 4.08
ICUI's Price/Peter Lynch Fair Value is ranked higher than
87% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. ICUI: 4.08 )
ICUI' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.62   Max: 13.02
Current: 4.08

0.62
13.02
Price/Graham Number 1.52
ICUI's Price/Graham Number is ranked higher than
91% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.07 vs. ICUI: 1.52 )
ICUI' s 10-Year Price/Graham Number Range
Min: 0.92   Max: 3.55
Current: 1.52

0.92
3.55
Earnings Yield (Greenblatt) 7.30
ICUI's Earnings Yield (Greenblatt) is ranked higher than
84% of the 260 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.30 vs. ICUI: 7.30 )
ICUI' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.4   Max: 14.4
Current: 7.3

1.4
14.4
Forward Rate of Return (Yacktman) 9.58
ICUI's Forward Rate of Return (Yacktman) is ranked higher than
83% of the 258 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.55 vs. ICUI: 9.58 )
ICUI' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -2.1   Max: 27.2
Current: 9.58

-2.1
27.2

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:IC7.Germany
ICU Medical, Inc. is a Delaware Corporation founded in 1984. The Company is engaged in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications. Its products improve patient outcomes by helping to prevent bloodstream infections and protect healthcare workers and patients from exposure to infectious diseases or hazardous drugs and monitoring continuous cardiac output of critical care patients. The Company's complete product line includes custom infusion systems, closed delivery systems for hazardous drugs, needle free infusion connectors, catheters and cardiac monitoring systems. Its products are used in hospitals and alternate medical sites in more than 50 countries throughout the world. Its products are categorized into three main product lines: Infusion Therapy, Critical Care and Oncology. Infusion Therapy: I.V. therapy lines, used in hospitals and ambulatory clinics, consist of a tube running from a bottle or plastic bag containing an I.V. solution to a catheter inserted in a patient's vein. The tube typically has several injection ports or Y-sites (conventionally, entry tubes covered by rubber caps) to which a secondary I.V. line can be connected to permit constant intravenous administration of medications, fluids and nutrients, and to allow instantaneous intravenous administration of emergency medication. Critical Care: Critical care products are used to monitor vital signs as well as specific physiological functions of key organ systems and Oncology: Oncology products are used to prepare and deliver hazardous medications such as those used in chemotherapy which, if released, can have harmful effects to the healthcare worker and environment. Manufacturing of its products involves injection molding of plastic and silicone parts, manual and automated assembly of the molded plastic parts, needles and other components, quality control inspection, packaging and sterilization. The Company currently sells all of its products to I.V. product manufacturers, independent distributors and direct sales to the end user. It competes with other manufacturers of closed system transfer devices for the safe handling of oncology drugs, notably Becton Dickinson, CareFusion and B Braun. The Company's products are subject to clearance by the United States Food and Drug Administration ("FDA") under a number of statutes including the Food Drug and Cosmetics Act ("FDC Act").
» More Articles for ICUI

Headlines

Articles On GuruFocus.com
Weekly CEO Buys Highlight: GE, ICUI, OPK, CLMS, AHH Mar 10 2014 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 2,388 Shares Nov 29 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 18,831 Shares Nov 24 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 1,406 Shares Nov 15 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 3,691 Shares Nov 09 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 1,500 Shares Nov 08 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 5,684 Shares Nov 05 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 1,000 Shares Nov 03 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 9,496 Shares Nov 02 2010 
ICU Medical Inc. Reports Operating Results (10-Q) Oct 22 2010 


More From Other Websites
Medtronic Up 1.9% on Favorable IN.PACT Admiral DCB Data Sep 18 2014
Covidien Announces Double-Digit Dividend Rise for 6th Year Sep 18 2014
TG Therapeutics (TGTX) in Focus: Stock Gains 16.1% Sep 18 2014
St. Jude Medical Comes Up with Positive CardioMEMS Data Sep 17 2014
Resmed-FairView Sleep Apnea Data Sharing Drags Shares Sep 17 2014
Medtronic Up on Launch of Wearable SEEQ MCT Monitor Sep 17 2014
Medtronic's CoreValve Emerges Cost-Efficient in New Trial Sep 16 2014
Covidien's Two Neurovascular Trial Enrolments on Track Sep 16 2014
CVS Health's MinuteClinic Debuts in St. Louis at 5 Stores Sep 12 2014
Medtronic Launches NC Euphora Balloon Catheter on FDA Nod Sep 12 2014
Medtronic Records First CoreValve Evolut R Implant in US Sep 11 2014
Baxter Names its New Spun-off Biopharmaceuticals Company Sep 11 2014
Chimerix (CMRX) in Focus: Stock Surges 11.8% Sep 10 2014
Medtronic Up on CE Mark Win for CoreValve Evolut R System Sep 08 2014
Medtronic Poised on Improved Q1, Covidien Buyout Plan Sep 05 2014
CareFusion Hits a New 52-Week High on Strong Q4 Results Sep 05 2014
New Clinical Study Shows ICU Medical Infusion Systems Are Associated with a Reduction in Both... Sep 05 2014
Resmed (RMD) Shares Up on Favorable Sleep Apnea Study Sep 04 2014
Meridian Bioscience Offers Testing Solutions to Premier Sep 04 2014
Alere Slips to Sell on Dismal Q2 Results Sep 03 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK